Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma

被引：2
|
作者：
Chirico, A. [1 ]
Henderson Berg, M. H. [1 ]
Roberge, D. [2 ]
Pehr, K. [1 ]
机构：
[1] McGill Univ, Div Dermatol, Montreal, PQ, Canada
[2] CHUM Hotel Dieu Montreal, Div Radiat Oncol, Montreal, PQ, Canada
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 02期
关键词：
D O I：
10.1111/bjd.19490
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：354 / 356
页数：3
相关论文
共 50 条
  • [1] Intralesional rituximab for indolent primary cutaneous B-cell lymphoma
    Besch-Stokes, Jake
    Bhullar, Puneet
    Puri, Pranav
    Boudreaux, Blake
    Costello, Collin
    Rule, William
    Rosenthal, Allison
    DiCaudo, David J.
    Pittelkow, Mark R.
    Mangold, Aaron
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB177 - AB177
  • [2] Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
    Menzer, Christian
    Rendon, Adriana
    Hassel, Jessica C.
    CANCERS, 2022, 14 (19)
  • [3] Treatment of primary cutaneous B-cell lymphoma with intralesional Rituximab®
    Fink-Puches, R
    Zalaudek, I
    Kerl, H
    Cerroni, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (03) : 759 - 759
  • [4] Intralesional and systemic rituximab in the treatment of primary cutaneous B-cell lymphoma
    Besch-Stokes, Jake G.
    Shahin, Ahmad
    Bhullar, Puneet
    Hwang, Angelina
    Kechter, Jacob
    Puri, Pranav
    Butterfield, Richard
    Costello, Collin
    Rule, William G.
    Rosenthal, Allison
    Dicaudo, David J.
    Pittelkow, Mark R.
    Mangold, Aaron R.
    JEADV CLINICAL PRACTICE, 2023, 2 (04): : 872 - 881
  • [5] Intralesional rituximab for cutaneous B-cell lymphoma
    Paul, T
    Radny, P
    Kröber, SM
    Paul, A
    Blaheta, HJ
    Garbe, C
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) : 1239 - 1243
  • [6] Intralesional Rituximab Treatment for Primary Cutaneous B-cell Lymphoma: Nine Finnish Cases
    Vakeva, Liisa
    Ranki, Annamari
    Malkonen, Tarja
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (03) : 396 - 397
  • [7] Rituximab treatment in primary cutaneous B-cell lymphoma
    Estrach, M. Teresa
    Lerma, Ingrid Lopez
    Herrera, Adriana Garcia
    Mascaro, Jose Manuel, Jr.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB138 - AB138
  • [8] Treatment of primary cutaneous B-cell lymphoma with rituximab
    Fink-Puches, R
    Wolf, IH
    Zalaudek, I
    Kerl, H
    Cerroni, L
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (05) : 847 - 853
  • [9] Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab
    Morales, Anjali V.
    Advani, Ranjana
    Horwitz, Steven M.
    Riaz, Nadeem
    Reddy, Sunil
    Hoppe, Richard T.
    Kim, Youn H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (06) : 953 - 957
  • [10] Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
    Penate, Y.
    Hernandez-Machin, B.
    Perez-Mendez, L. I.
    Santiago, F.
    Rosales, B.
    Servitje, O.
    Estrach, T.
    Fernandez-Guarino, M.
    Calzado, L.
    Acebo, E.
    Gallardo, F.
    Salar, A.
    Izu, R.
    Ortiz-Romero, P. L.
    Pujol, R. M.
    Fernandez-de-Misa, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (01) : 174 - 179
12345